KP Tissue Inc. (TSE:KPT – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$11.68 and traded as high as C$12.93. KP Tissue shares last traded at C$12.80, with a volume of 5,491 shares changing hands.
Analyst Upgrades and Downgrades
A number of equities analysts recently weighed in on the stock. Desjardins boosted their price objective on shares of KP Tissue from C$12.00 to C$12.50 and gave the stock a “hold” rating in a report on Friday, May 15th. TD increased their target price on KP Tissue from C$12.00 to C$14.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, KP Tissue has a consensus rating of “Hold” and an average price target of C$12.12.
View Our Latest Analysis on KP Tissue
KP Tissue Trading Down 0.8%
KP Tissue (TSE:KPT – Get Free Report) last issued its earnings results on Thursday, May 14th. The company reported C$0.22 earnings per share for the quarter. Sell-side analysts anticipate that KP Tissue Inc. will post 0.4398964 EPS for the current fiscal year.
KP Tissue Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 15th were paid a $0.21 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 6.6%. KP Tissue’s payout ratio is currently 80.00%.
Insider Buying and Selling at KP Tissue
In other news, Director David A. Spraley sold 3,668 shares of the business’s stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of C$13.30, for a total transaction of C$48,784.40. Following the completion of the transaction, the director directly owned 15,712 shares of the company’s stock, valued at C$208,969.60. The trade was a 18.93% decrease in their ownership of the stock. Insiders have sold 6,668 shares of company stock worth $87,644 over the last three months. 0.14% of the stock is owned by insiders.
KP Tissue Company Profile
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Recommended Stories
- Five stocks we like better than KP Tissue
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
